Her2 DNA vaccine as adjunct treatment for cancers in companion animals
    42.
    发明授权
    Her2 DNA vaccine as adjunct treatment for cancers in companion animals 有权
    Her2 DNA疫苗作为伴侣动物癌症的辅助治疗

    公开(公告)号:US09040053B2

    公开(公告)日:2015-05-26

    申请号:US13272651

    申请日:2011-10-13

    CPC classification number: A61K39/0011 A61K48/00 A61K2039/53 A61K2039/545

    Abstract: The application discloses therapeutic vaccines based upon the “pING” DNA plasmid vector expressing the gene encoding the rat Her2 protein. Vaccines according to the instant disclosure are used as an adjunct treatment for surgery, radiation and/or chemotherapy for dogs and cats with cancers that over express the Her2 antigen, and prolong the post-surgical disease free interval and/or survival time. Also included are therapeutically effective methods of immunization using said vaccines.

    Abstract translation: 该申请公开了基于表达编码大鼠Her2蛋白的基因的“pING”DNA质粒载体的治疗性疫苗。 根据本公开的疫苗被用作用于具有过表达Her2抗原的癌症的狗和猫的手术,放射和/或化学疗法的辅助治疗,并且延长了手术后无疾病间隔和/或存活时间。 还包括使用所述疫苗的治疗有效的免疫方法。

    PET CARE CLEANSING COMPOSITION
    46.
    发明申请

    公开(公告)号:US20190091133A1

    公开(公告)日:2019-03-28

    申请号:US15774534

    申请日:2016-11-09

    Applicant: MERIAL INC.

    Abstract: A method of treating the skin or hair on a dog containing an effective amount of an ectoparasiticide previously applied to the skin or hair, comprising applying a quantity of a cleansing composition directly to the skin or hair, wherein the treatment does not result in reducing the efficacy of the ectoparasiticide against adult fleas (C. felis) or adult ticks (R. sanguineus) below 90% efficacy for at least a month after application of the ectoparasiticide; wherein the cleansing composition comprises about 1-3% glycerin; about 2-4% silicone copolyol esters, water and is essentially free of surfactant.

Patent Agency Ranking